Skip to main content
. 2015 Sep 2;10:5609–5633. doi: 10.2147/IJN.S72330

Figure 11.

Figure 11

Release profiles of levodopa from the nanocomposite at pH 7.4 (A) and pH 4.8 (B).

Notes: Inset shows the release profiles of levodopa from the nanocomposite at pH 4.8 from 0 to 2,000 minutes. Reproduced with permission from Kura AU, Hussein Al Ali SH, Hussein MZ, Fakurazi S, Arulselvan P. Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent. Int J Nanomedicine. 2013;8:1103–1110.178